Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb randomized study of FSME IMMUN and Encepur TBE vaccines in children
2008-002691-10Phase 3Completed
- Sponsor
- Baxter International Inc.
- Start
- Aug 2008
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of FSME-IMMUN and Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE) (2 arms), sponsored by Baxter International Inc. Primary endpoint: Immunogenicity. Started Aug 2008; status: completed.
02
Drugs
FSME-IMMUNTick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2008-002691-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002691-10.